Mouse_NN
interleukin-2_NN
receptor_NN
alpha_NN
gene_NN
expression_NN
._.

Interleukin-1_NN
and_CC
interleukin-2_NN
control_VBP
transcription_NN
via_IN
distinct_JJ
cis-acting_JJ
elements_NNS
._.

We_PRP
have_VBP
shown_VBN
that_IN
interleukin-1_NN
-LRB-_-LRB-
IL-1_NN
-RRB-_-RRB-
and_CC
IL-2_NN
control_VBP
IL-2_NN
receptor_NN
alpha_NN
-LRB-_-LRB-
IL-2R_NN
alpha_NN
-RRB-_-RRB-
gene_NN
transcription_NN
in_IN
CD4-CD8_NN
-_:
murine_JJ
T_NN
lymphocyte_NN
precursors_NNS
._.

Here_RB
we_PRP
map_VBP
the_DT
cis-acting_JJ
elements_NNS
that_WDT
mediate_VBP
interleukin_NN
responsiveness_NN
of_IN
the_DT
mouse_NN
IL-2R_NN
alpha_NN
gene_NN
using_VBG
a_DT
thymic_JJ
lymphoma-derived_JJ
hybridoma_NN
-LRB-_-LRB-
PC60_NN
-RRB-_-RRB-
._.

The_DT
transcriptional_JJ
response_NN
of_IN
the_DT
IL-2R_NN
alpha_NN
gene_NN
to_TO
stimulation_NN
by_IN
IL-1_NN
+_CC
IL-2_NN
is_VBZ
biphasic_JJ
._.

IL-1_NN
induces_VBZ
a_DT
rapid_JJ
,_,
protein_NN
synthesis-independent_JJ
appearance_NN
of_IN
IL-2R_NN
alpha_NN
mRNA_NN
that_WDT
is_VBZ
blocked_VBN
by_IN
inhibitors_NNS
of_IN
NF-kappa_NN
B_NN
activation_NN
._.

It_PRP
also_RB
primes_VBZ
cells_NNS
to_TO
become_VB
IL-2_NN
responsive_JJ
and_CC
thereby_RB
prepares_VBZ
the_DT
second_JJ
phase_NN
,_,
in_IN
which_WDT
IL-2_NN
induces_VBZ
a_DT
100-fold_RB
further_JJ
increase_NN
in_IN
IL-2R_NN
alpha_NN
transcripts_NNS
._.

Transient_JJ
transfection_NN
experiments_NNS
show_VBP
that_IN
several_JJ
elements_NNS
in_IN
the_DT
promoter-proximal_JJ
region_NN
of_IN
the_DT
IL-2R_NN
alpha_NN
gene_NN
contribute_VBP
to_TO
IL-1_NN
responsiveness_NN
,_,
most_RBS
importantly_RB
an_DT
NF-kappa_NN
B_NN
site_NN
conserved_VBN
in_IN
the_DT
human_JJ
and_CC
mouse_NN
gene_NN
._.

IL-2_NN
responsiveness_NN
,_,
on_IN
the_DT
other_JJ
hand_NN
,_,
depends_VBZ
on_IN
a_DT
78-nucleotide_JJ
segment_NN
1.3_CD
kilobases_NNS
upstream_RB
of_IN
the_DT
major_JJ
transcription_NN
start_NN
site_NN
._.

This_DT
segment_NN
functions_VBZ
as_IN
an_DT
IL-2-inducible_JJ
enhancer_NN
and_CC
lies_VBZ
within_IN
a_DT
region_NN
that_WDT
becomes_VBZ
DNase_NN
I_NN
hypersensitive_JJ
in_IN
normal_JJ
T_NN
cells_NNS
in_IN
which_WDT
IL-2R_NN
alpha_NN
expression_NN
has_VBZ
been_VBN
induced_VBN
._.

IL-2_NN
responsiveness_NN
requires_VBZ
three_CD
distinct_JJ
elements_NNS
within_IN
the_DT
enhancer_NN
._.

Two_CD
of_IN
these_DT
are_VBP
potential_JJ
binding_VBG
sites_NNS
for_IN
STAT_NN
proteins_NNS
._.

